Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000102909-26-000256·VANGUARD GROUP INC
Schedule 13G ownership disclosure
Xeris Biopharma Holdings Inc
Common Stock · CUSIP: 98422E103
Event date: 2025-12-31
- Filing-level shares
- 11,186,677
- Percent of class
- 6.74%
- The Vanguard Group
Shares: 11,186,677 · Class: 6.74%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000102909-26-000256
- Form type
- SCHEDULE 13G/A
- Filer
- VANGUARD GROUP INC
- CIK
- CIK 102909
- Filed
- Jan 30, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership